Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,217,333 papers from all fields of science
Search
Sign In
Create Free Account
fordianoside
Known as:
(1S)-1,2,3,4-tetrahydro-7-hydroxy-1-((4-hydroxybenzyl)methyl)-2,2-dimethyl-8-O-isoquinolinyl beta-D-glucopyranoside
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Glucosides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A new alkaloid glycoside from the rhizomes of Aristolochia fordiana
Zhong-Bo Zhou
,
Jian-guang Luo
,
Ke Pan
,
L. Kong
Natural Product Research
2014
Corpus ID: 37575933
A new alkaloid glycoside named fordianoside (1), together with three known compounds arabinothalictoside (2), 6-O-p-coumaroyl…
Expand
Highly Cited
2007
Highly Cited
2007
Luminescent platinum(II) complexes containing isoquinolinyl indazolate ligands: synthetic reaction pathway and photophysical properties.
Sheng-Yuan Chang
,
J. Kavitha
,
+6 authors
A. Carty
Inorganic Chemistry
2007
Corpus ID: 40685927
New Pt(II) dichloride complexes [Pt(1-iqdzH)Cl2] (2a) and [Pt(3-iqdzH)Cl2] (2b), in which idqzH = 1- or 3-isoquinolinyl indazole…
Expand
2006
2006
Synthesis and Characterization of Isoquinolinyl Quinazolines and a Study of Their Antiviral and Antifungal Activities.
V. K. Pandey
,
L. P. Pathak
,
S. K. Mishra
2006
Corpus ID: 85402564
Anthranilic acid on treatment with an aromatic acid chloride in pyridine gives 2-aryl-4-oxo-3H-benzoxazines 1 which reacts with p…
Expand
2000
2000
Isoquinolinil carboxamids and its use with anti-conversion.
J. Harling
,
M. Thompson
2000
Corpus ID: 223437132
N- (5, 8-di-chloro-1, 2, 3, 4-tetrahydroisoquinolin-7-yl) -3-acetyl-4-isopropoxybenzamide or a pharmaceutically acceptable salt…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE